Current Opinion in Infectious Diseases

Article	Citations
Potential opportunities and challenges for infection prevention and control for cystic fibrosis in the modern era	65
Postexposure prophylaxis for occupational exposure to selected pathogens for healthcare personnel	61
La Crosse virus encephalitis in children	60
Skin and soft tissue infections in the elderly	52
Strongyloidiasis-related lung involvement: too much of a bad thing	48
Hematopoietic stem cell transplantation and cellular therapy in persons living with HIV	47
Skin and soft tissue infections: swab or biopsy? A diagnostic dilemma	43
Corticosteroids for viral central nervous system infections	41
Surgical management of cystic echinococcosis of the liver	39
Complexities of cardiomyopathy in septic shock	33
From diagnosis to management: current perspectives on congenital cytomegalovirus infection	33
Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside	33
Typhoid fever control in the 21st century: where are we now?	32
Bacterial cholesterol-dependent cytolysins and their interaction with the human immune response	31
Immunocompromised host section: Adoptive T-cell therapy for dsDNA viruses in allogeneic hematopoietic cell transplant recipients	30
Editorial introductions	30
Viral meningitis and encephalitis: an update	30
Babesiosis in immunosuppressed hosts: pathogenesis, diagnosis and management	30
Tissue resident memory T cells in respiratory infections	30
Managing cognitive impairment in people with HIV: Erratum	28
Resistant herpes simplex virus infections – who, when, and what's new?	27
Fusarium species central nervous system infection	27
Mpox in people living with HIV	26
The reemergence of Streptococcus pyogenes in skin and soft tissue infections: a review of epidemiology, pathogenesis, and management strategies	25
Malaria in pregnancy: baby steps	24

Follow-up blood culture in Gram-negative bacilli bacteraemia: for whom is follow-up blood culture useful?	24
Tropical infectious diseases and skin manifestations: a diagnostic framework	23
Mitigation of nontuberculous mycobacteria in hospital water: challenges for infection prevention	22
Does climate change threaten delivery of HIV care in resource-limited settings?	21
Tuberculosis molecular bacterial load assay in the management of tuberculosis	21
Tick-borne encephalitis	21
Appropriate surgical management in skin and soft tissue infections	20
Editorial introductions	20
Interventions for polyoma virus-associated hemorrhagic cystitis	18
Diagnostic stewardship: what impacts antibiotics use?	18
Using antibiotics wisely	18
New diagnostic strategies to distinguish Crohn's disease and gastrointestinal tuberculosis	17
Management of neonates born to mothers with active genital herpes simplex virus infection: an alternative approach	17
Gut microbiome and its clinical implications: exploring the key players in human health	17
Diagnostic approach and update on encephalitis	17
Recent advances in flavivirus encephalitis	17
Haemophilus ducreyi in genital ulcer disease: new developments in an old disease	17
CMV antiviral stewardship in transplantation – the next frontier	17
Risk stratification for selecting empiric antibiotherapy during and after COVID-19	16
The plumbing problem: rising antimicrobial resistance in building water systems	16
How to differentiate skin rash in covid, mononucleosis, chickenpox, sixth disease and measles	16
Large lessons learned from small vessels: coronary microvascular dysfunction in HIV	16
Respiratory syncytial virus in children: epidemiology and clinical impact post-COVID-19	15
Update on the treatment of chronic pulmonary aspergillosis	15
Prenatal and postnatal antiviral therapies for the prevention and treatment of congenital cytomegalovirus infections	15
Editorial introductions	15
The microbiota in respiratory tract infections: from association to intervention	15
Respiratory syncytial virus prevention in immunocompromised hosts: gaps and opportunities	14
Interpreting and managing preservation fluids positive for Gram-negative bacteria	14
The microbiome as a biomarker of anal precancerous lesions in people with HIV	14
Editorial: Pathogenesis and immune response – editorial	14
Childhood tuberculosis	14
Human adenovirus lung disease: outbreaks, models of immune-response-driven acute lung injury and pandemic potential	14
The role of macrolides in severe community-acquired pneumonia and the potential impact of macrolide-resistant Mycoplamsa pneumoniae	14
The secret weapon to reduce multidrug-resistant Gram-negative infections: can vaccines help decrease MDR risk?	14
Combatting antimicrobial-resistant Neisseria gonorrhoeae: new antibiotics and the pipeline of antigonococcal therapeutics	14
New trends in congenital syphilis: epidemiology, testing in pregnancy, and management	14
H5 and H9 avian influenza – potential re-emergent zoonotic threats to humans	13
Update on drug treatments for multidrug resistant tuberculosis	13
Travellers’ diarrhoea – solidifying our knowledgebase	13
Respiratory metagenomics: route to routine service	13
Data science for pediatric infectious disease: utilizing COVID-19 as a model	13
Advanced neuroimaging for central nervous system infections: when, where, how, and why?	13
Chronic persistent Norovirus in the immune-compromised host	13
Emerging infections in vulnerable hosts: Stenotrophomonas maltophilia and Elizabethkingia anophelis	12
Antibiotic therapy for nonfermenting Gram-negative bacilli infections: future perspectives	12
Emerging treatment options for skin and soft tissue infections tailoring drug selection to individual patients	12
Short treatment duration for community-acquired pneumonia	12
An overview of risk factors, management and prevention of cochlear implant infections	12
The disease burden of respiratory syncytial virus in Infants	11

Skin and soft tissue infections in solid organ transplants	11
Neurobrucellosis	11
Antiviral therapies for respiratory syncytial virus infection: current expectations	11
Urinary tract infections in immunocompromised patients	11
Short-course antibiotic strategies for ventilator-associated pneumonia	11
Identifying patients with difficult-to-treat acute bacterial skin infections	11
A new era of HIV care for age-associated multimorbidity	11
Anti-inflammatory therapies for bronchiectasis	11
Burden of influenza in the elderly: a narrative review	10
Updates on the neurological manifestations of SARS-CoV-2 infection	10
Resurgence of Mycoplasma pneumoniae infections in children: emerging challenges and opportunities	10
Latent tuberculosis screening and treatment in solid organ and hematopoietic stem cell transplant candidates and recipients	10
Genetic mechanisms underlying host susceptibility to central nervous system viral infections	10
The evolution of knowledge for treating Gram-negative bacterial infections	9
Genome-wide approaches to bacterial strain typing: a history and review of recent methodological advances	9
Duration of antibiotic therapy in Gram-negative infections with a particular focus on multidrug-resistant pathogens	9
Surgical site infection prophylaxis: what have we learned and are we making progress?	9
Endemic, epidemic and pandemic infections: the roles of natural and acquired herd immunity	9
Pneumocystis jirovecii in solid organ transplant recipients: updates in epidemiology, diagnosis, treatment, and prevention	9
Endemic viral infections in immunocompromised hosts: Dengue, Chikungunya, Zika	9
Live vaccines in solid organ transplant recipients	9
Chagas disease in the immunocompromised host	9
Therapeutic agents for the treatment of human mpox	9
Immune responses and severe dengue: what have we learned?	9
Effective strategies for managing trimethoprim-sulfamethoxazole and levofloxacin-resistant Stenotrophomonas maltophilia infections: bridging the gap between scientific evidence and clinical practice	9
Eravacycline: from clinical trials to its potential place in everyday therapy	8
The role of older antibiotics in the treatment of skin and soft tissue infections: current perspectives	8
Editorial introductions	8
Chimeric antigen receptor-T-cell therapies going viral: latent and incidental viral infections	8
How I manage patients with New Delhi metallo-beta-lactamase and OXA-48-producing Enterobacterales infections: a practical approach	8
Tropical gastrointestinal infections of contemporary public health importance	8
Management of nonfermenting gram-negative infections: a critique of the guidelines	8
Editorial introductions	8
Mycetoma, chromoblastomycosis and other deep fungal infections: diagnostic and treatment approach	8
The implications of the COVID-19 pandemic for long term care facilities	8
Universal versus targeted treatment of neonatal herpes simplex virus among neonates presenting for sepsis evaluations	8
Editorial introductions	7
Antiviral therapies for influenza	7
An update on infectious encephalitis: from epidemiology to management	7
Editorial introductions	7
Recent advances in the management of skin and soft tissue infections	7
The power of story: what Victorian novels can teach us about public health	7
Preventing respiratory viral transmission in healthcare settings	7
When is it a sexually transmitted infection? Intimate contact transmission of pathogens not traditionally defined as STIs	7
Medical management of cystic echinococcosis	7
Community-acquired skin and soft-tissue infections in people who inject drugs	7
Editorial: Friends and foes: “The quarrels of friends are the opportunities of foes”	7
Long COVID in children and young people: then and now	7
Pneumocystis jiroveci: still troublesome to diagnose and treat	7
Empirical antibiotic therapy for difficult-to-treat Gram-negative infections: when, how, and how long?	6
Is it possible to identify genotypes underlying resistant phenotypes in Gram-negative pathogens?	6
Risk factors for cognitive decline in persons with HIV	6
Donor-derived latent viral and parasitic infections in solid organ transplant recipients: old foes and emerging challenges	6
Shifting the power: scale-up of access to point-of-care and self-testing for sexually transmitted infections in low-income and middle-income settings	6
Editorial introductions	6
Current status of primary, secondary and tertiary prevention of congenital cytomegalovirus disease: a call to action	6
Horizontal versus vertical strategies for infection prevention: current practices and controversies	6
Giardia and growth impairment in children in high-prevalence settings: consequence or co-incidence?	6
Risk factors for severity in seasonal respiratory viral infections and how they guide management in hematopoietic cell transplant recipients	6
From clinical trials to daily practice: how to adequately administer sulbactam-durlobactam? alone or combined with imipenem?	6
Human toxoplasmosis: current advances in the field	6
Redefining tissue immunity: lessons from the CNS and beyond	6
Climate change and resilience for antimicrobial stewardship and infection prevention	6
Escherichia coli 0157:H7 virulence factors and the ruminant reservoir	5
Editorial introductions	5
Vitamin D for tuberculosis or acute respiratory infections: lost in translation?	5
The role of sulbactam-durlobactam in treating carbapenem-resistant Acinetobacter infections	5
The microbiology and pathogenesis of nonfermenting Gram-negative infections	5
Managing multidrug resistant Gram-negative bacteraemia in immunocompromised hosts	5
Brain abscess in immunocompetent patients: recent findings	5
Editorial introductions	5
Central nervous system infections in the tropics	5
Nontyphoidal Salmonella infections acquired from poultry	5
Advances and challenges in sexually transmitted infections prevention among men who have sex with men in Asia	5
To proceed or delay? The dilemma of community-acquired respiratory viruses in adults and pediatrics before allogeneic stem cell transplantation and chimeric-antigen-receptor T-cell therapy	5
Skin and soft tissue infections due to rapidly growing mycobacteria	5
Antiviral combination treatment strategies for SARS-CoV-2 infection in immunocompromised patients	5
Cutaneous manifestations associated with HIV preexposure prophylaxis: what to expect and when to worry	5
Current challenges in neurocysticercosis: recent data and where we are heading	5
Vaccine hesitancy and other challenges to sexually transmitted infection vaccine acceptance	5

Neutropenia and antibiotics: when, what, how and why?	5
Lenacapavir: a first-in-class capsid inhibitor for HIV treatment and prevention	5
‘No cyst, no echinococcosis’: a scoping review update on the diagnosis of cystic echinococcosis after the issue of the WHO-IWGE Expert Consensus and current perspectives	5
Adjuvanted recombinant zoster vaccine in solid organ transplant and hematopoietic stem-cell transplant recipients	5
Dengue encephalitis: what's new?	5
Strongyloides stercoralis infection in solid organ transplant recipients	5
Viral infections and inborn errors of immunity	5
Viral diarrheas – newer advances in diagnosis and management	5
The role of the genital microbiota in the acquisition and pathogenesis of sexually transmitted infections	4
Hot topics in pediatric infectious diseases: vaccines, molecular diagnosis, and emerging challenges post COVID-19	4
Updates on diagnosis and management of parasitic infections of the central nervous system	4
Current challenges in acute bacterial skin infection management	4
Endemic mycoses – are we making progress in management?	4
Impact of respiratory viral infections on nasopharyngeal pneumococcal colonization dynamics in children	4
Mpox exposure and transmission in healthcare settings during the 2022 global outbreak	4
Editorial introductions	4
The present and future of blood virome in allogeneic hematopoietic cell transplant recipients	4
A work in progress: antimicrobial stewardship in solid organ transplant patient populations	4
Editorial introductions	4
Host-directed immunotherapy for viral infections	4
Lenacapavir and the novel HIV-1 capsid inhibitors: an emerging therapy in the management of multidrug-resistant HIV-1 virus	4
Epidemiology of Gram-negative bacteria during coronavirus disease 2019. What is the real pandemic?	4
Antiviral prophylaxis against herpesviruses (herpes simplex virus, varicella-zoster virus and cytomegalovirus) among patients with cancer	4
Respiratory viral infections in children with cancer and febrile neutropenia and children undergoing hematopoietic stem cell transplantation	4
Infant feeding: emerging concepts to prevent HIV transmission	4
Clinical trials that could change the management of severe multidrug-resistant Gram-negative infections	4
New antibiotics in clinical pipeline for treating infections caused by metallo-β-lactamases producing Gram-negative bacteria	4
When antimicrobial stewardship begins with microbiological test requests: the case of asymptomatic bacteriuria	4
How to treat severe Acinetobacter baumannii infections	4
Left ventricular assist device-associated driveline infections as a specific form of complicated skin and soft tissue infection/acute bacterial skin and skin structure infection – issues and therapeut	4
Hyperammonemia syndrome in immunosuppressed individuals	4
Mpox: emergence following smallpox eradication, ongoing outbreaks and strategies for prevention	4
NSAIDs for early management of acute respiratory infections	4
Gastrointestinal involvement in post-acute Coronavirus disease (COVID)-19 syndrome	4
HIV and menopause: current evidence, gaps, and future directions for integrated care	4
Infectious mononucleosis: new concepts in clinical presentation, epidemiology, and host response	4